Pan-Cdk inhibitor ZK304709 suppresses Cdc20 expression and potentiates the anticancer activity of apcin in HeLa cervical cancer cells Cover

.blurhash-client-img { display: none !important; }

Pan-Cdk inhibitor ZK304709 suppresses Cdc20 expression and potentiates the anticancer activity of apcin in HeLa cervical cancer cells

Acta Pharmaceutica

By: Xiangyang Le , Qingsong Chen , Shuyang Cao , Gaoyun Hu, Qianbin Li and Zhuo Chen

Open Access

|Dec 2025

Metrics

DOI: https://doi.org/10.2478/acph-2026-0002 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Accepted on: Oct 5, 2025

Published on: Dec 17, 2025

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

cell division cycle 20 homologue,

cyclin-dependent kinase 1,

combination chemotherapy,

synergistic effects,

anti-tumour activity

Related subjects:

Pharmacy, other

© 2025 Xiangyang Le, Qingsong Chen, Shuyang Cao, Gaoyun Hu, Qianbin Li, Zhuo Chen, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.